270 related articles for article (PubMed ID: 2935516)
1. The mechanism of tolerance induction of tumor-specific delayed-type hypersensitivity responses by intravenous inoculation of tumor cells.
Sato S; Fukuzawa M; Nakajima H; Ogata M; Kosugi A; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Nov; 76(11):1099-106. PubMed ID: 2935516
[TBL] [Abstract][Full Text] [Related]
2. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
[TBL] [Abstract][Full Text] [Related]
4. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
Qian J; Hashimoto T; Fujiwara H; Hamaoka T
J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
[TBL] [Abstract][Full Text] [Related]
5. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
Kosugi A; Takai Y; Ogata M; Fujiwara H; Hamaoka T
J Leukoc Biol; 1985 May; 37(5):629-39. PubMed ID: 3156939
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of the capacity of delayed-type hypersensitivity responses to alloantigens by intravenous injection of neuraminidase-treated allogeneic cells.
Sano S; Suda T; Qian JH; Sato S; Ikegami R; Hamaoka T; Fujiwara H
J Immunol; 1987 Dec; 139(11):3652-9. PubMed ID: 3680947
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory pathways in adult responder mice. III. Establishment of a GAT-specific suppressor T cell clone from GAT-tolerant responders which afferently regulates DTH responses.
Jenkins MK; Miller SD
J Mol Cell Immunol; 1985; 2(1):1-13. PubMed ID: 2978221
[TBL] [Abstract][Full Text] [Related]
8. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
[TBL] [Abstract][Full Text] [Related]
9. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
10. The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells.
Shimizu Y; Fujiwara H; Ueda S; Wakamiya N; Kato S; Hamaoka T
Eur J Immunol; 1984 Sep; 14(9):839-43. PubMed ID: 6236991
[TBL] [Abstract][Full Text] [Related]
11. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
[TBL] [Abstract][Full Text] [Related]
12. Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo.
Bril H; van den Akker TW; Molendijk-Lok BD; Bianchi AT; Benner R
J Immunol; 1984 Feb; 132(2):599-604. PubMed ID: 6228591
[TBL] [Abstract][Full Text] [Related]
13. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
15. Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity.
Liew FY; Scott MT; Liu DS; Croft SL
J Immunol; 1987 Oct; 139(7):2452-7. PubMed ID: 2958550
[TBL] [Abstract][Full Text] [Related]
16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
17. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
[TBL] [Abstract][Full Text] [Related]
18. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Shimizu Y; Takai Y; Wakamiya N; Ueda S; Kato S; Hamaoka T
Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
[TBL] [Abstract][Full Text] [Related]
19. A cascade of T-T interactions, mediated by the linked recognition of antigen, in the induction of T cells able to help delayed-type hypersensitivity responses.
Bretscher PA
J Immunol; 1986 Dec; 137(12):3726-33. PubMed ID: 2431041
[TBL] [Abstract][Full Text] [Related]
20. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
